| Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma F Ahmad, D Dixit, V Sharma, A Kumar, SD Joshi, C Sarkar, E Sen Cell death & disease 7 (5), e2213-e2213, 2016 | 109 | 2016 |
| Integrating molecular subclassification of medulloblastomas into routine clinical practice: a simplified approach K Kaur, A Kakkar, A Kumar, S Mallick, PK Julka, D Gupta, A Suri, V Suri, ... Brain Pathology 26 (3), 334-343, 2016 | 80 | 2016 |
| Telomerase reverse transcriptase (TERT)‐enhancer of zeste homolog 2 (EZH2) network regulates lipid metabolism and DNA damage responses in glioblastoma F Ahmad, S Patrick, T Sheikh, V Sharma, P Pathak, PB Malgulwar, ... Journal of neurochemistry 143 (6), 671-683, 2017 | 54 | 2017 |
| Genome‐wide small noncoding RNA profiling of pediatric high‐grade gliomas reveals deregulation of several mi RNA s, identifies downregulation of sno RNA cluster HBII‐52 and … P Jha, R Agrawal, P Pathak, A Kumar, S Purkait, S Mallik, V Suri, ... International journal of cancer 137 (10), 2343-2353, 2015 | 50 | 2015 |
| Oncogenic KIAA1549-BRAF fusion with activation of the MAPK/ERK pathway in pediatric oligodendrogliomas A Kumar, P Pathak, S Purkait, M Faruq, P Jha, S Mallick, V Suri, ... Cancer genetics 208 (3), 91-95, 2015 | 33 | 2015 |
| Novel internal regulators and candidate miRNAs within miR-379/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma S Nayak, M Aich, A Kumar, S Sengupta, P Bajad, P Dhapola, D Paul, ... Scientific reports 8 (1), 1-10, 2018 | 32 | 2018 |
| Loss-of-function mutations in Calcitonin receptor (CALCR) identify highly aggressive glioblastoma with poor outcome J Pal, V Patil, A Kumar, K Kaur, C Sarkar, K Somasundaram Clinical Cancer Research 24 (6), 1448-1458, 2018 | 32 | 2018 |
| Genetic alterations related to BRAF‐FGFR genes and dysregulated MAPK/ERK/m TOR signaling in adult pilocytic astrocytoma P Pathak, A Kumar, P Jha, S Purkait, M Faruq, A Suri, V Suri, MC Sharma, ... Brain pathology 27 (5), 580-589, 2017 | 30 | 2017 |
| Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs) A Kakkar, A Majumdar, A Kumar, M Tripathi, P Pathak, MC Sharma, V Suri, ... Epilepsy research 127, 141-151, 2016 | 30 | 2016 |
| Expression of DNA methyltransferases 1 and 3B correlates with EZH2 and this 3-marker epigenetic signature predicts outcome in glioblastomas S Purkait, V Sharma, A Kumar, P Pathak, S Mallick, P Jha, MC Sharma, ... Experimental and molecular pathology 100 (2), 312-320, 2016 | 28 | 2016 |
| ATRX in diffuse gliomas with its mosaic/heterogeneous expression in a subset S Purkait, CA Miller, A Kumar, V Sharma, P Pathak, P Jha, MC Sharma, ... Brain Pathology 27 (2), 138-145, 2017 | 27 | 2017 |
| PI3K/AKT/mTOR signaling pathway activity in IDH-mutant diffuse glioma and clinical implications E Mohamed, A Kumar, Y Zhang, AS Wang, K Chen, Y Lim, A Shai, ... Neuro-oncology 24 (9), 1471-1481, 2022 | 26 | 2022 |
| Evaluation of 1p and 14q status, MIB-1 labeling index and progesterone receptor immunoexpression in meningiomas: Adjuncts to histopathological grading and predictors of … S Kumar, A Kakkar, V Suri, A Kumar, U Bhagat, MC Sharma, M Singh, ... Neurology India 62 (4), 376-382, 2014 | 26 | 2014 |
| CXCL14 promotes a robust brain tumor-associated immune response in glioma A Kumar, E Mohamed, S Tong, K Chen, J Mukherjee, Y Lim, CM Wong, ... Clinical Cancer Research 28 (13), 2898-2910, 2022 | 25 | 2022 |
| Clinicopathological characteristics, molecular subgrouping, and expression of miR-379/miR-656 cluster (C14MC) in adult medulloblastomas K Kaur, A Kakkar, A Kumar, S Purkait, S Mallick, V Suri, MC Sharma, ... Journal of neuro-oncology 130, 423-430, 2016 | 23 | 2016 |
| Clinicopathological and molecular characteristics of pediatric meningiomas S Battu, A Kumar, P Pathak, S Purkait, L Dhawan, MC Sharma, A Suri, ... Neuropathology 38 (1), 22-33, 2018 | 22 | 2018 |
| Outcomes of pediatric glioblastoma treated with adjuvant chemoradiation with temozolomide and correlation with prognostic factors S Mallick, AK Gandhi, NP Joshi, A Kumar, T Puri, DN Sharma, KP Haresh, ... Indian journal of medical and paediatric oncology 36 (02), 99-104, 2015 | 22 | 2015 |
| Identification of miR-379/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas A Kumar, S Nayak, P Pathak, S Purkait, PB Malgulawar, MC Sharma, ... Journal of Neuro-oncology 139, 23-31, 2018 | 20 | 2018 |
| Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors V Sharma, S Purkait, S Takkar, PB Malgulwar, A Kumar, P Pathak, V Suri, ... Brain tumor pathology 33, 117-128, 2016 | 18 | 2016 |
| Prognostic stratification of GBMs using combinatorial assessment of IDH1 mutation, MGMT promoter methylation, and TERT mutation status: experience from a tertiary care center … S Purkait, S Mallick, V Sharma, A Kumar, P Pathak, P Jha, A Biswas, ... Translational oncology 9 (4), 371-376, 2016 | 16 | 2016 |
